According to the latest report by IMARC Group, titled “Dengue Testing Market Growth: Global Industry Trends, Share, Size, Opportunity and Forecast 2022-2027”, the global dengue testing market reached a value of US$ 522.6 Million in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 726.34 Million by 2027, exhibiting a CAGR of 5.40% during 2022-2027.
Dengue or breakbone fever is a viral infection that spreads via the bite of an infected Aedes aegypti mosquito. It causes headaches; muscle, bone and joint aches; high fever; abdominal pain; vomiting, pain behind the eyes; swollen glands; difficulty breathing; mild bleeding in the nose and gums; and rashes. It is diagnosed using dengue testing, including RT-PCR, Dengue IgG/IgM rapid tests, and enzyme-linked immunosorbent assay (ELISA), which medical professionals conduct to identify the different serotypes of the dengue virus and if the patient is infected with the dengue virus or not.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/dengue-testing-market/requestsample
Dengue Testing Market Trends and Drivers:
The market is primarily driven by the increasing number of dengue cases due to the changing climatic conditions and poor sanitation, resulting in breeding sites for mosquitos. Due to this, governments of various countries are spreading awareness among the masses by educating them about distress of dengue.
They are also encouraging people to prevent dengue by self-protection and thermal fogging of insecticides, which represents another growth-inducing factor. Additionally, accurate diagnosis plays a crucial role in clinical care as it assists in outbreak control, case confirmation, vaccine development, pathogenesis, clinical trials, early detection of severe cases, academic research, and differential diagnosis of other infectious diseases.
These benefits are accelerating the demand for dengue testing kits across the globe. Other factors, including rapid urbanization, advancements in the healthcare industry, and significant investments by manufacturers in research and development (R&D) activities to create highly efficient, cost-effective dengue test kit, are also contributing to the market growth.
|Dengue Testing Market Report Scope|
|Market size value in 2021||US$ 522.6 Million|
|Market forecast in 2027||US$ 726.34 Million|
|Growth Rate||CAGR of 5.40% from 2022 to 2027|
|Base year for estimation||2021|
Global Dengue Testing Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, Abnova Corporation, CerTest Biotec S.L., DiaSorin S.p.A., F. Hoffmann-La Roche AG, InBios International Inc., NovaTec Immundiagnostica GmbH, OriGene Technologies Inc., PerkinElmer Inc., Quest Diagnostics Incorporated and Thermo Fisher Scientific Inc.
The report has segmented the market on the basis of region, test type and end user.
Breakup by Test Type:
- ELISA-based Tests
- RT-PCR based Tests
- Dengue IgG/IgM Rapid Test
Breakup by End User:
- Diagnostic Centers
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/dengue-testing-market
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800